Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

GERON CORP (GERN) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

GERON CORP (GERN), most recent 12 months reported: net loss $67.61M, free cash flow -$114.76M. Latest balance sheet on file: liquid cash $300.85M. From SEC filings. Others in Pharmaceutical Preparations: Faeth Therapeutics, Inc. · FULCRUM THERAPEUTICS, INC. · GALECTIN THERAPEUTICS INC. · GAIN THERAPEUTICS, INC · GREENWICH LIFESCIENCES, INC. · Genprex, Inc. · GEOVAX LABS, INC. · Structure Therapeutics Inc.

Stock screener

Watchlist